Experimental stroke induces massive, rapid activation of the peripheral immune system

Journal of Cerebral Blood Flow and Metabolism

Volumn 26, Issue 5, 2006, Pages 654-665

  Offner, Halina ^a,b   Subramanian, Sandhya ^a   Parker, Susan M ^b   Afentoulis, Michael E ^a   Vandenbark, Arthur A ^a,b,c   Hurn, Patricia D ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chemokines; Cytokines; Peripheral immunity; Receptors; Stroke

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENCEPHALITIS; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPH NODE; LYMPHOID ORGAN; MALE; MEDIATOR RELEASE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINAL CORD; SPLEEN; SPLEEN CELL; STROKE; T LYMPHOCYTE;

EID: 33646382597     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600217     Document Type: Article

References (40)

1. Allan SM, Rothwell NJ (2001) Cytokine and acute neurodegeneration. Nat Rev 2:734-44
2. Allan SM, Rothwell NJ (2003) Inflammation in central nervous system injury. Philos Trans Roy Soc London 358:1669-77
3. Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapies. J Cerebral Blood Flow Metab 19:819-34
4. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci 94:10873-8
5. Cartier L, Hartley O, Dubois-Dauphin M, Krause K-H (2005) Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Rev 48:16-42
6. Chiodini RJ, Buergelt CD (1993) Susceptibility of Balb/c, C57/B6 and C57/B10 mice to infection with Mycobacterium paratuberculosis. J Comp Pathol 109:309-19
7. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore MP, Eckenstein F (2000) Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31:1715-20
8. del Zoppo GJ, Becker KJ, Hallenbeck JM (2001) Inflammation after stroke: is it harmful? Arch Neurol 58:669-72
9. Emsley HCA, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139:93-101
10. Fu D, Ng YK, Gan P, Ling EA (2004) Permanent occlusion of the middle cerebral artery upregulates expression of cytokines and neuronal nitric oxide synthase in the spinal cord and urinary bladder in the adult rat. Neuroscience 125:819-31
11. Gendron A, Teitelbaum J, Cossette C, Nuara S, Dumont M, Geadah D, du Souch P, Kouassi E (2002) Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 955:85-97
12. Hauben E, Butovsky O, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Leibowitz-Amit R, Pevsner E, Akselrod S, Neeman M, Cohen IR, Schwartz M (2000) Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 20:6421-30
13. Kajioka EH, Andres ML, Nelson GA, Gridley DS (2000) Immunologic variables in maleand femaleC57BL/6 mice from two sources. Comp Med 50:288-91
14. Kim JS, Gautam SC, Chopp M, Zaloga C, Jones ML, Ward PA, Welch KMA (1995) Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 56:127-34
15. Kohm AP, Sanders VM (2001) Norepinephrin and B2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487-525
16. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GF (1994) Tumor necrosis factor α expression in ischemic neurons. Stroke 25:1481-8
17. Liu T, McDonnell PC, White RF, Barone FC, Feuerstein GF (1993) Interleukin-1B mRNA expression in ischemic rat cortex. Stroke 24:1746-51
18. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD (2003) Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 23:8701-5
19. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-55
20. Nadareishvili ZG, Li H, Wright V, Maric D, Warach S, Hallenbeck JM, Dambrosia J, Barker JL, Baird AE (2004) Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death. Neurology 63:1446-51
21. O'Neill LA, Kaltschmidt C (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-8
22. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post-stroke T helper cell type 1-like immunostimulation. J Exp Med 198:725-36
23. Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD (2000) Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in femalemouse. J Cereb Blood Flow Metab 20:112-8
24. Smith CJ, Emsley HCA, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-termoutcome. BMC Neurol 4:2
25. Spleiss O, Gourmala N, Boddeke H, Sauter A, Fiebich BL, Berger M, Gebicke-Haertere PJ (1998) Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of mRNA in ischemic and endotoxinemic rat brain. J Neurosci Res 53:15-28
26. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP (2002) The use of flow cytometry to evaluate temporal changes in inflammatory cells followingfocal cerebral ischemia in mice. Brain Res 932:110-9
27. Stoll G (2002) Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia. Rev Nerol 158:887-91
28. Swanson MA, Lee WT, Sanders VM (2001) IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol 166:232-240
29. Takami S, Minami M, Nagata I, Namura S, Satoh M (2001) Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1430-5
30. Takami S, Minami M, T K, Nagata I, Namura S, Satoh M (2002) TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J Cerebral Blood Flow Metab 22:780-784
31. Vollenweider F, Herrmann MM, Otten U (2003) Interleukin-6 expression and localization after transient global ischemia in gerbil hippocampus. Neurosci Lett 341:49-52
32. Wang X, Schmidt DB, Foley JJ, Barone FC, Ames RS, Sarau HM (2000) Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Mol Pharmacol 57:1190-8
33. Wang XK, Barone FC, Aiyar NV, Feuerstein GF (1997) Increased interleukin-1 receptor and interleukin-1 receptor antagonist gene expression after focal stroke. Stroke 28:155-62
34. Wang XK, Ellison JA, Siren A-L, Lysko PG, Yue T-L, Barone FC, Shatzman A, Feuerstein GF (1998) Prolonged expression of interferon inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in the rat. J Neurochem 71:1194-204
35. Wang XK, Yue T-L, Barone FC, Feuerstein GF (1995a) Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in rat ischemic cortex. Stroke 26:661-6
36. Wang XK, Yue T-L, Young PR, Barone FC, Feuerstein GZ (1995b) Expression of interleukin-6, c-fos and zif268 mRNA in rat ischemic cortex. J Cereb Blood Flow Metab 15:166-71
37. Wang XK, Yue T-L, Barone FC, White RF, Young PR, McDonnell PC, Feuerstein GZ (1994) Concomitant cortical expression of TNFα and IL-IB mRNA following transient focal ischemia. Mol Chem Neuropathol 23:103-14
38. Wu YP, Ling EA (1998a) Expression of Fos in the spinal motoneurons labeled by horseradish peroxidase followingmiddle cerebral artery occlusion. Brain Res Bull 45:571-6
39. Wu YP, Ling EA (1998b) Transynaptic changes of neurons and associated microglial reaction in the spinal cord of rats followingmiddle cerebral artery occlusion. Neurosci Lett 256:41-4
40. Zheng Z, Yenari MA (2004) -ischemic inflammation: molecular mechanisms and therapeutic implications. Neurological Res 26:884-92